Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis induced by β3-adrenoceptor agonist in human omental adipocytes

Diabetes

Volumn 48, Issue 1, 1999, Pages 117-120

  Umekawa, Tsunekazu ^a   Yoshida, Toshihide ^a   Sakane, Naoki ^a   Kogure, Akinori ^a   Kondo, Motoharu ^a   Honjyo, Hideo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ARGININE; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; HEXYLUREA; ISOPRENALINE; TRYPTOPHAN; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; L 755507; PROPANOLAMINE DERIVATIVE; SULFONAMIDE;

ADIPOCYTE; ADULT; ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIPOLYSIS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OMENTUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WEIGHT GAIN; ADIPOSE TISSUE; AMINO ACID SEQUENCE; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PHYSIOLOGY;

ADIPOSE TISSUE; ADRENERGIC BETA-AGONISTS; ADULT; AMINO ACID SEQUENCE; FEMALE; HUMANS; ISOPROTERENOL; LIPOLYSIS; MIDDLE AGED; MUTATION; OMENTUM; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; SULFONAMIDES;

EID: 0032589914     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.1.117     Document Type: Article

References (36)

1. 3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol 266:R1371-R1382, 1994
2. 3-Adrenoceptor: an update. Eur J Endocrinol 132:377-385, 1995
3. 3-radrenergic receptor gene. J Biol Chem 270:29483-29492, 1995
4. Hollenga C, Brouwer F, Zaagsma J: Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyles types. Eur J Pharmacol 200:325-330, 1991
5. 3-adrenoceptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol 199:291-301, 1991
6. 3-radrenergic effect on lipolysis in human subcutaneous adipose tissue. J Clin Endocrinol Metab 77:352-355, 1993
7. Van Liefde I, Van Ermen A, Vanquelin G: No functional atypical β-adrenergic receptors in human omental adipocytes. Life Sci 54:209-214, 1994
8. 3-adrenergic receptor. Science 245:1118-1121, 1989
9. 3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
10. 3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289:223-228, 1995
11. 3-adrenergie receptor. Eur J Biochem 224:761-770, 1994
12. 3-adrenoceptor in man. Br J Pharmacol 110:929-936, 1993
13. 3-adrenoceptors in obesity. J Clin Invest 95:1109-1116, 1995
14. 3-adrenoceptor in man. J Clin Invest 95:2239-2245, 1995
15. 3-adrenoceptors with low lipolytic and human subcutaneous white adipocytes. J Lipid Res 37:87-97, 1996
16. 3-adrenoceptor sensitivity in visceral adipose tissue. Diabetotogia 39:838-844, 1996
17. 3-adrenergic receptor gene. N Engl J Med 333:343-347, 1995
18. 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
19. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354, 1995
20. 3-adrenergic receptor gene and response to treatment of obesity (Letter). Lancet 346:1433-1434, 1995
21. 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 20:1887-1890, 1997
22. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215:555-560, 1995
23. 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 83:2441-2444, 1998
24. 3-adrenergic receptor agonist increases metabolic rate in rhesus monkey. J Clin Invest 101:2387-2393, 1998
25. 3-Adrenergic agonists: potential therapeutics for obesity. Exp Opin Invest Drugs 6:1811-1825, 1997
26. 3-adrenoceptor agonist, on lipolysis of human and rat adipocytes. Horm Metab Res 28:394-396, 1996
27. 3-adrenoceptor agonist, on lipolysis of epididymal, mesenteric, and subcutaneous adipocytes in rats. Endocrine J 44:181-185, 1997
28. Rodbell M: Metabolism of isolated fat cells. 1. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380, 1964
29. 3-adrenergic receptor polymorphism: a genetic marker for visceral fat obesity and insulin resistance syndrome. Diabetologia 40:200-204, 1997
30. 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39:857-860, 1996
31. 3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int J Obesity 20:428-434, 1996
32. 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue. Diabetologia 40:838-842, 1997
33. 3-Adrenergic receptor gene variant and lipid metabolism in Pima Indians. Diabetologia 40:123-124, 1997
34. 3-adrenergic receptor mutant. Endocrinology 137:2638-2641, 1996
35. 3-adrenoceptor activity. Eur J Biochem 247:1174-1179, 1997
36. 3-adrenergic receptors under the control of human gene regulatory elements. Diabetes 47:1464-1471, 1998